BVS vs RUN · rev $573.3M vs P/E 6.0, rev $2.04B
Bioventus Inc (BVS) versus Sunrun Inc (RUN) — a side-by-side from cached financials, not a winner call.
Bioventus Inc (BVS) is a medical devices company listed on US.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Latest reported BVS revenue for 2024-12-31 was $573.3M. Net income was -$43.8M. Revenue was up 11.9% from 2023-12-31 to 2024-12-31. BVS currently screens at market cap $495.1M.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
BVS currently screens at market cap $495.1M. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Not investment advice. Open the BVS and RUN stock pages for the full models.
Not investment advice.